The ODYSSEY DM-DYSLIPIDEMIA Trial: Confirming the Benefits of Alirocumab in Diabetic Mixed Dyslipidemia
Annals of Translational Medicine - China
doi 10.21037/atm.2017.10.26
Full Text
Open PDFAbstract
Available in full text
Categories
Date
December 1, 2017
Authors
Publisher
AME Publishing Company